These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 15106307)
1. [Macrolides in modern therapy of bacterial infections. Spectrum of efficacy characteristics and pharmacological activity]. Budanov SV; Vasil'ev AN; Smirnova LB Antibiot Khimioter; 2003; 48(11):15-22. PubMed ID: 15106307 [No Abstract] [Full Text] [Related]
2. [Do ketolides have real advantages over macrolides?]. Muñoz Bellido JL; García-Rodríguez JA Rev Esp Quimioter; 2003 Sep; 16(3):273-6. PubMed ID: 14702118 [No Abstract] [Full Text] [Related]
3. [New therapeutic uses of the macrolides]. Mihălţan F Pneumologia; 2004; 53(3):100-4. PubMed ID: 16108157 [No Abstract] [Full Text] [Related]
4. [Bacterial internalization and intracellular activity of quinolones and macrolides]. Bellussi L; De Benedetto M; Lauriello M; Passali GC; Passali D Acta Otorhinolaryngol Ital; 2007 Apr; 27(2 Suppl 87):1-11. PubMed ID: 17702375 [No Abstract] [Full Text] [Related]
5. [Clinical basis of macrolides apply in diseases of the respiratory tract]. Płusa T Pol Merkur Lekarski; 2008 Nov; 25(149):432-6. PubMed ID: 19177783 [TBL] [Abstract][Full Text] [Related]
6. New macrolide, lincosaminide and streptogramin B antibiotics. Kirst HA Expert Opin Ther Pat; 2010 Oct; 20(10):1343-57. PubMed ID: 20645886 [TBL] [Abstract][Full Text] [Related]
7. Telithromycin. Raja A; Lebbos J; Kirkpatrick P Nat Rev Drug Discov; 2004 Sep; 3(9):733-4. PubMed ID: 15368658 [No Abstract] [Full Text] [Related]
8. Infection site concentrations: their therapeutic importance and the macrolide and macrolide-like class of antibiotics. Drusano GL Pharmacotherapy; 2005 Dec; 25(12 Pt 2):150S-158S. PubMed ID: 16305286 [TBL] [Abstract][Full Text] [Related]
10. Two cases of macrolide resistance in Mycoplasma pneumoniae acquired during the treatment period. Itagaki T; Suzuki Y; Seto J; Abiko C; Mizuta K; Matsuzaki Y J Antimicrob Chemother; 2013 Mar; 68(3):724-5. PubMed ID: 23152478 [No Abstract] [Full Text] [Related]
11. [New antibacterial agents]. Järvinen A; Valtonen V Duodecim; 2000; 116(24):2803-5. PubMed ID: 12077883 [No Abstract] [Full Text] [Related]
12. Looking for new preparations for antibacterial therapy. IV. New antimicrobial agents from the aminoglycoside, macrolide and tetracycline groups in clinical trials. Karpiuk I; Tyski S Przegl Epidemiol; 2015; 69(4):723-9, 865-70. PubMed ID: 27139351 [TBL] [Abstract][Full Text] [Related]
13. The role of atypical infections and macrolide therapy in patients with asthma. Rollins DR; Good JT; Martin RJ J Allergy Clin Immunol Pract; 2014; 2(5):511-7. PubMed ID: 25213043 [TBL] [Abstract][Full Text] [Related]
14. New agents in development for the treatment of bacterial infections. Abbanat D; Morrow B; Bush K Curr Opin Pharmacol; 2008 Oct; 8(5):582-92. PubMed ID: 18761107 [TBL] [Abstract][Full Text] [Related]